NCT03450473View on ClinicalTrials.gov

A Prospective Case Series Evaluating Surgimend Mp® In Patients Undergoing Complex Abdominal Hernia Repair

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 3, 2018

Primary Completion Date

March 11, 2022

Study Completion Date

December 31, 2022

Conditions
Hernia, Ventral
Interventions
DEVICE

SurgiMend® MP

SurgiMend MP® is an acellular dermal tissue matrix derived from bovine dermis. The device is supplied sterile in a variety of sizes to be trimmed by the surgeon to meet the individual patient's needs. SurgiMend MP® will be used for abdominal wall reinforcement in patients with complex ventral hernia repair.

Trial Locations (1)

63110

Barnes Jewish Hospital, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT03450473 - A Prospective Case Series Evaluating Surgimend Mp® In Patients Undergoing Complex Abdominal Hernia Repair | Biotech Hunter | Biotech Hunter